Both RGS1 and RASGRP1 variants associated with systemic lupus erythematosus, Crohn’s disease, rheumatoid arthritis, multiple sclerosis, blood pressure, type 1 diabetes, type 2 diabetes, urinary metabolites and response to chemotherapy. Here, RASGRP1 is linked to systemic lupus erythematosus.